Conquering Diseases

Anticoagulant Study For Patients With Atrial Fibrillation After Aortic Valve Implantation


Seeking men and women 18 years and older who have undergone a successful replacement of narrowed aortic valve and require treatment with oral blood thinners.


We are studying the effect of an new/investigational anticoagulant drug versus the standard treatment. The treatments will be compared for safety with regards to bleeding.

What we're hoping for

Evaluate the safety and effectiveness of the investigational drug in patients with atrial fibrillation following aortic valve implantation (TAVI).

Additional Information Identifier: NCT02943785

 Principal Investigator

Nikolaos  Kakouros, MD

UMass Memorial Health Care

 Study Contact

Cardiovascular Research Office

(508) 856-1014


UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655